VI
MNTA

Versor Investments’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Versor Investments’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-950,199
Closed -$49.9M – 313
2020
Q3 		$49.9M Buy
+950,199
New +$39.3M 4.23% 11

Versor Investments's MNTA Position: Q4 2020 in Review

Versor Investments sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 950,199 shares — an estimated $49.9M sold.

Versor Investments first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $49.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Versor Investments reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Versor Investments sold 950,199 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $49.9M.
  • Versor Investments first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Versor Investments's Momenta Pharmaceuticals, Inc. position peaked at $49.9M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Versor Investments's 13F filing for Q4 2020, filed 10 Feb 2021.